Government ❯Regulatory Bodies ❯Food and Drug Administration (FDA)

Drug Approval

Mifepristone Regulation Wegovy Expanded Approval Counterfeit Drug Identification Drug Shortage Monitoring

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Despite previous assurances, Eli Lilly is unable to meet the demand for its weight loss drug Zepbound, causing significant disruptions for patients.

CDC Investigates Multistate Botulism-Like Illnesses Linked to Counterfeit Botox

Wegovy Approved for Heart Health, Faces Insurance Coverage Challenges